MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
This Quarter Return
+7.18%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$540M
AUM Growth
+$540M
(-1.8%)
Cap. Flow
-$25.1M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
18.67%
Holding
222
New
30
Increased
26
Reduced
119
Closed
26
Top Buys
| 1 |
Core Scientific
CORZ
|
$4.85M |
| 2 |
Limbach Holdings
LMB
|
$4.43M |
| 3 |
ECG
Everus Construction Group, Inc.
ECG
|
$4.36M |
| 4 |
Boot Barn
BOOT
|
$4.23M |
| 5 |
Archrock
AROC
|
$3.97M |
Top Sells
| 1 |
Credo Technology Group
CRDO
|
$9.59M |
| 2 |
ICF International
ICFI
|
$7.55M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$7.33M |
| 4 |
ALTR
Altair Engineering Inc. Class A Common Stock
ALTR
|
$7.19M |
| 5 |
Amphastar Pharmaceuticals
AMPH
|
$4.87M |
Sector Composition
| 1 | Financials | 23.65% |
| 2 | Healthcare | 14.74% |
| 3 | Industrials | 14.59% |
| 4 | Technology | 12.45% |
| 5 | Consumer Discretionary | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Repligen
RGEN
$6.54B
| – | – |
-1,505
| Closed | -$224K |
|
202
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-271
| Closed | -$285K |
|
203
Qualys
QLYS
$4.9B
| – | – |
-19,937
| Closed | -$2.56M |
|
204
Oscar Health
OSCR
$4.57B
| – | – |
-148,318
| Closed | -$3.15M |
|
205
Onto Innovation
ONTO
$5.03B
| – | – |
-1,159
| Closed | -$241K |
|
206
Merck
MRK
$210B
| – | – |
-2,483
| Closed | -$282K |
|
207
Lyft
LYFT
$7.02B
| – | – |
-15,385
| Closed | -$196K |
|
|
208
ICF International
ICFI
$1.77B
| – | – |
-45,263
| Closed | -$7.55M |
|
209
General Dynamics
GD
$86.8B
| – | – |
-665
| Closed | -$201K |
|
210
Evolent Health
EVH
$1.11B
| – | – |
-50,259
| Closed | -$1.42M |
|
211
Cytokinetics
CYTK
$5.98B
| – | – |
-46,731
| Closed | -$2.47M |
|
212
Cirrus Logic
CRUS
$5.81B
| – | – |
-1,697
| Closed | -$211K |
|
213
Chord Energy
CHRD
$6.12B
| – | – |
-1,750
| Closed | -$228K |
|
214
CACI
CACI
$10.3B
| – | – |
-853
| Closed | -$430K |
|
215
BellRing Brands
BRBR
$5.27B
| – | – |
-4,112
| Closed | -$250K |
|
216
Atkore
ATKR
$1.9B
| – | – |
-28,840
| Closed | -$2.44M |
|
217
Ascendis Pharma
ASND
$12.1B
| – | – |
-1,520
| Closed | -$227K |
|
218
Arrowhead Research
ARWR
$3.84B
| – | – |
-48,961
| Closed | -$948K |
|
|
219
Amphastar Pharmaceuticals
AMPH
$1.37B
| – | – |
-100,340
| Closed | -$4.87M |
|
220
Amkor Technology
AMKR
$5.88B
| – | – |
-6,737
| Closed | -$206K |
|
221
Aflac
AFL
$57.1B
| – | – |
-21,509
| Closed | -$2.4M |
|
222
Axcelis
ACLS
$2.47B
| – | – |
-26,874
| Closed | -$2.82M |
|